ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1952

Dermatoscopy Limitation and the Critical Role of Capillaroscopy in Systemic Sclerosis and Raynaud’s Phenomenon among African American Veterans

Genessis Maldonado1, Maurizio Cutolo2, Tracy Frech1, Mislav Radic3, Marcus Snow4 and Vanessa Smith5, 1Vanderbilt University Medical Center, Nashville, TN, 2University of Genova, Genova, Italy, 3University Hospital Split, Division of Rheumatology and Clinical Immunology, Split, Croatia, Split, Croatia, 4University of Nebraska Medical Center, Omaha, NE, 5Ghent University Hospital, Gent, Belgium

Meeting: ACR Convergence 2025

Keywords: Imaging, race/ethnicity, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1936–1971) Imaging of Rheumatic Diseases Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Nailfold capillaroscopy (NFC) is an essential tool for evaluating microvascular abnormalities in patients with Raynaud’s phenomenon (RP) in United States (U.S.) Veterans (1). While dermatoscopy is an acceptable and cost-effective screening method for nailfold assessment in systemic sclerosis (SSc), published guidelines highlight the importance of clear image acquisition for appropriate interpretation (2). The objective of this project was assessment of NFC in patients with concern for connective tissue disease (CTD)-related RP to determine whether different intensities of skin pigmentation impacts the interpretability of dermatoscopy screening.

Methods: Patients undergoing evaluation for CTD-related RP were consented for participation in Institutional Review Board approved research at the time of care at the Veterans Affairs (VA) Hospital (No. 1618579-17). Patients were prepared for NFC per published protocols (3). Images were obtained with two devices available at the VA Hospital, a dermatoscope attached to a smart phone (200X magnification, smart phone focus) and Smart G-Scope (250X magnification, USB automatic focus). Each image was classified for the clarity of image by two capillaroscopy experts. Microvascular findings for capillary density, apical enlargement, hemorrhages, and abnormal shapes were determined by the capillarscopy.io software application.

Results: A total of 38 U.S. Veterans were assessed for RP by NFC using clinically available two devices. Among these, 28% (n=11) of subjects were classified as African American. As shown in Table 1, dermatoscopy produced blurry images in 63.6% (7/11) of patients with Fitzpatrick skin type IV and V and 37% (10/31) in Fitzpatrick skin type I, II, and III. In 45.5% (5/11) of dermatoscopy exams in Fitzpatrick skin type IV and V skin were deemed uninterpretable compared to 37% (10/31) of Fitzpatrick skin type I, II, and III (kappa statistic >0.9). Smart G-Scope improved interpretability across the cohort of patients (Table 2), especially in Fitzpatrick Skin Types IV and V. A scleroderma (SD)-pattern characteristic of scleroderma microangiopathy was detected by the Smart-G-scope in 3 of those 5 uninterpretable dermatoscope acquired images (Table 3).

Conclusion: In patients with CTD-related RP, particularly among African American Veterans, a dermatoscopy device led to a high rate of uninterpretable examinations. The Smart-G USB device improved diagnosis of abnormal NFC. These results highlight that reliance on dermatoscopy alone as a screening tool may risk underdiagnosing microvascular involvement in SSc.References:1. Frech TM et al. BMC Rheumatol. 2021; 15; 5 (1): 42. 2. Radic M et al. Clin Exp Rheumatol. 2020; 38 Suppl 125 (3): 132-136. 3. Smith V et al. Autoimmun Rev. 2020; 9 (3): 102458.

Supporting image 1Table 1: Demographic data

Supporting image 2Table 2: Nailfold capillaroscopy characteristics

Supporting image 3Table 3: Capillaroscopy findings in the uninterpretable group.


Disclosures: G. Maldonado: None; M. Cutolo: None; T. Frech: None; M. Radic: None; M. Snow: None; V. Smith: Argenx, 2, Boehringer-Ingelheim, 2, 5, 6, GlaxoSmithKlein(GSK), 2, Janssen, 2, 5, 6.

To cite this abstract in AMA style:

Maldonado G, Cutolo M, Frech T, Radic M, Snow M, Smith V. Dermatoscopy Limitation and the Critical Role of Capillaroscopy in Systemic Sclerosis and Raynaud’s Phenomenon among African American Veterans [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/dermatoscopy-limitation-and-the-critical-role-of-capillaroscopy-in-systemic-sclerosis-and-raynauds-phenomenon-among-african-american-veterans/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dermatoscopy-limitation-and-the-critical-role-of-capillaroscopy-in-systemic-sclerosis-and-raynauds-phenomenon-among-african-american-veterans/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology